ACT-541468 Uses, Dosage, Side Effects and more
ACT-541468 is under investigation in clinical trial NCT03101189 (A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects).
| Trade Name | ACT-541468 |
| Generic | Nemorexant |
| Nemorexant Other Names | ACT-541468 |
| Type | |
| Formula | C23H23ClN6O2 |
| Weight | Average: 450.93 Monoisotopic: 450.1571017 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
